2019
DOI: 10.1111/trf.15555
|View full text |Cite
|
Sign up to set email alerts
|

Transfusion‐related immunomodulation: gamma irradiation alters the effects of leukoreduction on alloimmunization

Abstract: BACKGROUND: Adverse events following blood transfusion include allosensitization and generalized immunosuppression, collectively referred to as transfusion-related immune modulation. We evaluated the immunological effects of red blood cell (RBC) and platelet transfusions on alloantibody responses and on immunoregulatory cells in nonimmunosuppressed patients undergoing cardiovascular surgery. ABBREVIATIONS: FITC = fluorescein isothiocyanate; HLA = human leukocyte antigen; IFN-γ = interferon-γ; iNKT = invariant … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 31 publications
(55 reference statements)
0
9
0
Order By: Relevance
“…Consistently, in studies that evaluated the side effects of pathogen reduction technology (through UV illumination), gamma‐irradiated products are usually examined as a radiation control comparable to nontreated PLTs 26,27,50,71 . However, given some reports about lower posttransfusion efficacy and safety of gamma‐irradiated PCs 31–33,72 and proteomics‐based studies that highlight higher levels of PSL in these products compared to nonirradiated ones, 29,51 the study presented here for the first time investigated the levels of ROS generation in gamma‐irradiated PCs compared to nonirradiated PLTs. Our research emerges that gamma irradiation can significantly increase cytosolic ROS generation in two different phases, one at an earlier stage upon irradiation and another after longer storage of PLTs.…”
Section: Resultsmentioning
confidence: 99%
“…Consistently, in studies that evaluated the side effects of pathogen reduction technology (through UV illumination), gamma‐irradiated products are usually examined as a radiation control comparable to nontreated PLTs 26,27,50,71 . However, given some reports about lower posttransfusion efficacy and safety of gamma‐irradiated PCs 31–33,72 and proteomics‐based studies that highlight higher levels of PSL in these products compared to nonirradiated ones, 29,51 the study presented here for the first time investigated the levels of ROS generation in gamma‐irradiated PCs compared to nonirradiated PLTs. Our research emerges that gamma irradiation can significantly increase cytosolic ROS generation in two different phases, one at an earlier stage upon irradiation and another after longer storage of PLTs.…”
Section: Resultsmentioning
confidence: 99%
“…Compared with allogeneic blood transfusion, ANH autologous blood transfusion is performed by drawing autologous blood before surgery and returning it to the patient during surgery, which not only reduces the loss of red blood cells and platelets during surgery, but also has a short storage time and does not require refrigeration, so the blood components are less damaged, which facilitates the patient's postoperative recovery. CRP, TNF-α, and IL-6 are all key cytokines that initiate inflammatory or immune responses when the body perceives inflammatory stimuli such as trauma ( 17 , 18 ). In this study, 5d after operation, the CRP, TNF-α, and IL-6 of the allogeneic group were higher than those before operation, and the autologous group was lower than that of the allogeneic group ( P < 0.05).…”
Section: Discussionmentioning
confidence: 99%
“…As previously mentioned, leukoreduction may decrease HLA alloimmunization risk, but the risk varies with underlying diagnosis, history of pregnancy, and transfusion exposures. 33,36 Nonimmune causes of platelet refractoriness include sepsis, splenomegaly, disseminated intravascular coagulation, and medications. 37 Once nonimmune causes are excluded, a platelet antibody screen should be performed to evaluate plateletrefractory patients.…”
Section: Modern Applications Of Directed Donationmentioning
confidence: 99%